These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20173034)

  • 1. Use of the kinase inhibitor analog 1NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step.
    Sugi T; Kato K; Kobayashi K; Watanabe S; Kurokawa H; Gong H; Pandey K; Takemae H; Akashi H
    Eukaryot Cell; 2010 Apr; 9(4):667-70. PubMed ID: 20173034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.
    Johnson SM; Murphy RC; Geiger JA; DeRocher AE; Zhang Z; Ojo KK; Larson ET; Perera BG; Dale EJ; He P; Reid MC; Fox AM; Mueller NR; Merritt EA; Fan E; Parsons M; Van Voorhis WC; Maly DJ
    J Med Chem; 2012 Mar; 55(5):2416-26. PubMed ID: 22320388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
    Rutaganira FU; Barks J; Dhason MS; Wang Q; Lopez MS; Long S; Radke JB; Jones NG; Maddirala AR; Janetka JW; El Bakkouri M; Hui R; Shokat KM; Sibley LD
    J Med Chem; 2017 Dec; 60(24):9976-9989. PubMed ID: 28933846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single mutation in the gatekeeper residue in TgMAPKL-1 restores the inhibitory effect of a bumped kinase inhibitor on the cell cycle.
    Sugi T; Kawazu S; Horimoto T; Kato K
    Int J Parasitol Drugs Drug Resist; 2015 Apr; 5(1):1-8. PubMed ID: 25941623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift Assays.
    Scheele S; Geiger JA; DeRocher AE; Choi R; Smith TR; Hulverson MA; Vidadala RSR; Barrett LK; Maly DJ; Merritt EA; Ojo KK; Van Voorhis WC; Parsons M
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potential Toxoplasma gondii CDPK1 inhibitors with new scaffolds based on the combination of QSAR and scaffold-hopping method with in vitro validation.
    Zhang P; Jia L; Tian Y; Xi L; Duan R; Chen X; Xiao J; Yao X; Lan J; Li S
    Chem Biol Drug Des; 2020 May; 95(5):476-484. PubMed ID: 31436911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase.
    Donald RG; Zhong T; Wiersma H; Nare B; Yao D; Lee A; Allocco J; Liberator PA
    Mol Biochem Parasitol; 2006 Sep; 149(1):86-98. PubMed ID: 16765465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase.
    Kieschnick H; Wakefield T; Narducci CA; Beckers C
    J Biol Chem; 2001 Apr; 276(15):12369-77. PubMed ID: 11154702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.
    Ojo KK; Larson ET; Keyloun KR; Castaneda LJ; Derocher AE; Inampudi KK; Kim JE; Arakaki TL; Murphy RC; Zhang L; Napuli AJ; Maly DJ; Verlinde CL; Buckner FS; Parsons M; Hol WG; Merritt EA; Van Voorhis WC
    Nat Struct Mol Biol; 2010 May; 17(5):602-7. PubMed ID: 20436472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
    Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
    Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1NM-PP1 treatment of mice infected with Toxoplasma gondii.
    Sugi T; Kato K; Kobayashi K; Kurokawa H; Takemae H; Gong H; Recuenco FC; Iwanaga T; Horimoto T; Akashi H
    J Vet Med Sci; 2011 Oct; 73(10):1377-9. PubMed ID: 21685719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mutations in TgMAPK1 of Toxoplasma gondii conferring resistance to 1NM-PP1.
    Sugi T; Kobayashi K; Takemae H; Gong H; Ishiwa A; Murakoshi F; Recuenco FC; Iwanaga T; Horimoto T; Akashi H; Kato K
    Int J Parasitol Drugs Drug Resist; 2013 Dec; 3():93-101. PubMed ID: 24533298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
    Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis.
    Janetka JW; Hopper AT; Yang Z; Barks J; Dhason MS; Wang Q; Sibley LD
    J Med Chem; 2020 Jun; 63(11):6144-6163. PubMed ID: 32420739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma.
    Lourido S; Shuman J; Zhang C; Shokat KM; Hui R; Sibley LD
    Nature; 2010 May; 465(7296):359-62. PubMed ID: 20485436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the essential Kinase PfCDPK1 from Plasmodium falciparum in Toxoplasma gondii facilitates the discovery of novel antimalarial drugs.
    Gaji RY; Checkley L; Reese ML; Ferdig MT; Arrizabalaga G
    Antimicrob Agents Chemother; 2014 May; 58(5):2598-607. PubMed ID: 24550330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
    Moine E; Dimier-Poisson I; Enguehard-Gueiffier C; Logé C; Pénichon M; Moiré N; Delehouzé C; Foll-Josselin B; Ruchaud S; Bach S; Gueiffier A; Debierre-Grockiego F; Denevault-Sabourin C
    Eur J Med Chem; 2015 Nov; 105():80-105. PubMed ID: 26479029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.
    Zhang Z; Ojo KK; Johnson SM; Larson ET; He P; Geiger JA; Castellanos-Gonzalez A; White AC; Parsons M; Merritt EA; Maly DJ; Verlinde CL; Van Voorhis WC; Fan E
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5264-7. PubMed ID: 22795629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the Target of an Antiparasitic Compound in
    Herneisen AL; Sidik SM; Markus BM; Drewry DH; Zuercher WJ; Lourido S
    ACS Chem Biol; 2020 Jul; 15(7):1801-1807. PubMed ID: 32597628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.
    Vidadala RS; Rivas KL; Ojo KK; Hulverson MA; Zambriski JA; Bruzual I; Schultz TL; Huang W; Zhang Z; Scheele S; DeRocher AE; Choi R; Barrett LK; Siddaramaiah LK; Hol WG; Fan E; Merritt EA; Parsons M; Freiberg G; Marsh K; Kempf DJ; Carruthers VB; Isoherranen N; Doggett JS; Van Voorhis WC; Maly DJ
    J Med Chem; 2016 Jul; 59(13):6531-46. PubMed ID: 27309760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.